Treatment with interleukin (IL) inhibitors appear to be associated with an increased risk of serious infections, opportunistic infections and cancer in rheumatology patients, according to a systemic review and meta-analysis published in in JAMA Network Open this fall. This study was selected by Rheumatology Network as among the most noteworthy of 2019. Learn more in this slideshow.
In this month's rheumatoid arthritis quiz, we focus on tests used to diagnose rheumatoid arthritis. Plus, is it DXA or DEXA? (©Kentoh,AdobeStock,279475413); (©Valentina,AdobeStock_296476228)